# Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

> **NCT00331344** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 100 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate
- Recurrent Prostate Cancer
- Stage IV Prostate Cancer

## Interventions

- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** ixabepilone
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00331344
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331344, "Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00331344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*